메뉴 건너뛰기




Volumn 44, Issue 6, 2010, Pages 537-541

Interleukin-6 gene -174 C/G and apolipoprotein E gene polymorphisms and the risk of Alzheimer disease in a Polish population

Author keywords

Alzheimer disease; APOE; Interleukin 6; Polish population; Polymorphism; Risk factor

Indexed keywords

APOLIPOPROTEIN E; INTERLEUKIN 6;

EID: 78651237486     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.1016/S0028-3843(14)60149-3     Document Type: Article
Times cited : (12)

References (33)
  • 1
    • 0031843262 scopus 로고    scopus 로고
    • Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: Implications for neuritic plaque formation in Alzheimer's disease
    • Sheng J.G., Griffin W.S., Royston M.C., et al. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropathol Appl Neurobiol 1998; 24: 278-283.
    • (1998) Neuropathol Appl Neurobiol , vol.24 , pp. 278-283
    • Sheng, J.G.1    Griffin, W.S.2    Royston, M.C.3
  • 2
    • 0030250567 scopus 로고    scopus 로고
    • Inflammation and Alzheimer's disease pathogenesis
    • Rogers J., Webster S., Lue L.F., et al. Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging 1996; 17: 681-686.
    • (1996) Neurobiol Aging , vol.17 , pp. 681-686
    • Rogers, J.1    Webster, S.2    Lue, L.F.3
  • 3
    • 0029986869 scopus 로고    scopus 로고
    • Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques
    • Hüll M., Berger M., Volk B., et al. Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques. Ann N Y Acad Sci 1996; 17: 205-212.
    • (1996) Ann N Y Acad Sci , vol.17 , pp. 205-212
    • Hüll, M.1    Berger, M.2    Volk, B.3
  • 4
    • 0025763298 scopus 로고
    • Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices
    • Bauer J., Strauss S., Schreiter-Gasser U., et al. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett 1991; 8: 111-114.
    • (1991) FEBS Lett , vol.8 , pp. 111-114
    • Bauer, J.1    Strauss, S.2    Schreiter-Gasser, U.3
  • 5
    • 23944449670 scopus 로고    scopus 로고
    • Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain
    • Hampel H., Haslinger A., Scheloske M., et al. Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain. Eur Arch Psychiatry Clin Neurosci 2005; 255: 269-278.
    • (2005) Eur Arch Psychiatry Clin Neurosci , vol.255 , pp. 269-278
    • Hampel, H.1    Haslinger, A.2    Scheloske, M.3
  • 7
    • 0037072285 scopus 로고    scopus 로고
    • Interleukin-6 and risk of cognitive decline: Macarthur studies of successful aging
    • Weaver J.D., Huang M.H., Albert M., et al. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002; 13: 371-378. (Pubitemid 34857929)
    • (2002) Neurology , vol.59 , Issue.3 , pp. 371-378
    • Weaver, J.D.1    Huang, M.-H.2    Albert, M.3    Harris, T.4    Rowe, J.W.5    Seeman, T.E.6
  • 8
    • 2442533101 scopus 로고    scopus 로고
    • Inflammatory proteins in plasma and the risk of dementia: The Rotterdam study
    • Engelhart M.J., Geerlings M.I., Meijer J., et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol 2004; 61: 668-672.
    • (2004) Arch Neurol , vol.61 , pp. 668-672
    • Engelhart, M.J.1    Geerlings, M.I.2    Meijer, J.3
  • 9
    • 42149157698 scopus 로고    scopus 로고
    • Plasma beta amyloid and cytokine profile in women with Alzheimer's disease
    • Baranowska-Bik A., Bik W., Wolinska-Witort E., et al. Plasma beta amyloid and cytokine profile in women with Alzheimer's disease. Neuro Endocrinol Lett 2008; 29: 75-79.
    • (2008) Neuro Endocrinol Lett , vol.29 , pp. 75-79
    • Baranowska-Bik, A.1    Bik, W.2    Wolinska-Witort, E.3
  • 10
    • 41449104291 scopus 로고    scopus 로고
    • Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease
    • Bermejo P., Martín-Aragón S., Benedí J., et al. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. Immunol Lett 2008; 15: 198-202.
    • (2008) Immunol Lett , vol.15 , pp. 198-202
    • Bermejo, P.1    Martín-Aragón, S.2    Benedí, J.3
  • 11
    • 0033966340 scopus 로고    scopus 로고
    • Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-anti chymo trypsin in patients with Alzheimer's disease: Peripheral inflammation or signals from the brain?
    • Licastro F., Pedrini S., Caputo L., et al. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-anti chymo trypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol 2000; 1: 97-102.
    • (2000) J Neuroimmunol , vol.1 , pp. 97-102
    • Licastro, F.1    Pedrini, S.2    Caputo, L.3
  • 12
    • 0029417080 scopus 로고
    • Interleukin-1beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
    • DOI 10.1016/0304-3940(95)12192-7
    • Blum-Degen D., Müller T., Kuhn W., et al. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 1995; 202: 17-20. (Pubitemid 26014811)
    • (1995) Neuroscience Letters , vol.202 , Issue.1-2 , pp. 17-20
    • Blum-Degena, D.1    Muller, T.2    Kuhn, W.3    Gerlach, M.4    Przuntek, H.5    Riederer, P.6
  • 13
    • 0032189103 scopus 로고    scopus 로고
    • The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemiconset juvenile chronic arthritis
    • Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemiconset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
    • (1998) J Clin Invest , vol.102 , pp. 1369-1376
    • Fishman, D.1    Faulds, G.2    Jeffery, R.3
  • 14
    • 6944229787 scopus 로고    scopus 로고
    • Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: Geographic allele and genotype variations in Europe
    • Capurso C., Solfrizzi V., D'Introno A., et al. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp Gerontol 2004; 39: 1567-1573.
    • (2004) Exp Gerontol , vol.39 , pp. 1567-1573
    • Capurso, C.1    Solfrizzi, V.2    D'Introno, A.3
  • 16
    • 0345269140 scopus 로고    scopus 로고
    • Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk
    • Faltraco F., Bürger K., Zill P., et al. Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J Am Geriatr Soc 2003; 51: 578-579.
    • (2003) J Am Geriatr Soc , vol.51 , pp. 578-579
    • Faltraco, F.1    Bürger, K.2    Zill, P.3
  • 18
    • 0037120334 scopus 로고    scopus 로고
    • The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected]
    • Pola R., Flex A., Gaetani E., et al. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected]. Neuroreport 2002; 16: 1645-1647.
    • (2002) Neuroreport , vol.16 , pp. 1645-1647
    • Pola, R.1    Flex, A.2    Gaetani, E.3
  • 19
    • 0037042091 scopus 로고    scopus 로고
    • Effect of IL-6 polymorphism on risk of Alzheimer disease: Genotype-phenotype association study in Japanese cases
    • Shibata N., Ohnuma T., Takahashi T., et al. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 2002; 8: 436-439.
    • (2002) Am J Med Genet , vol.8 , pp. 436-439
    • Shibata, N.1    Ohnuma, T.2    Takahashi, T.3
  • 20
    • 33645037988 scopus 로고    scopus 로고
    • Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population
    • Koivisto A.M., Helisalmi S., Pihlajamäki J., et al. Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population. J Neurogenet 2005; 19: 155-161.
    • (2005) J Neurogenet , vol.19 , pp. 155-161
    • Koivisto, A.M.1    Helisalmi, S.2    Pihlajamäki, J.3
  • 21
    • 2942531060 scopus 로고    scopus 로고
    • Interleukin-6 promoter polymorphism: Risk and pathology of Alzheimer's disease
    • Zhang Y., Hayes A., Pritchard A., et al. Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease. Neurosci Lett 2004; 20: 99-102.
    • (2004) Neurosci Lett , vol.20 , pp. 99-102
    • Zhang, Y.1    Hayes, A.2    Pritchard, A.3
  • 22
    • 0034617348 scopus 로고    scopus 로고
    • Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease
    • DOI 10.1016/S0304-3940(00)01185-X, PII S030439400001185X
    • Bhojak T.J., DeKosky S.T., Ganguli M., et al. Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett 2000; 7: 21-24. (Pubitemid 30408429)
    • (2000) Neuroscience Letters , vol.288 , Issue.1 , pp. 21-24
    • Bhojak, T.J.1    Dekosky, S.T.2    Ganguli, M.3    Kamboh, M.I.4
  • 24
    • 56649117352 scopus 로고    scopus 로고
    • Polymorphism 174 G/C of interleukin 6 gene in Alzheimer's disease - Preliminary report
    • Paradowski B., Celczyñska D., Dobosz T., et al. Polymorphism 174 G/C of interleukin 6 gene in Alzheimer's disease - preliminary report. Neurol Neurochir Pol 2008; 42: 312-315.
    • (2008) Neurol Neurochir Pol , vol.42 , pp. 312-315
    • Paradowski, B.1    Celczyñska, D.2    Dobosz, T.3
  • 25
    • 0034616230 scopus 로고    scopus 로고
    • Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population
    • DOI 10.1016/S0304-3940(00)00917-4, PII S0304394000009174
    • Bagli M., Papassotiropoulos A., Knapp M., et al. Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett 2000; 7: 109-112. (Pubitemid 30156745)
    • (2000) Neuroscience Letters , vol.283 , Issue.2 , pp. 109-112
    • Bagli, M.1    Papassotiropoulos, A.2    Knapp, M.3    Jessen, F.4    Luise, R.M.5    Maier, W.6    Heun, R.7
  • 26
    • 33745959062 scopus 로고    scopus 로고
    • Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: A prospective casecohort study
    • van Oijen M., Hofman A., Soares H.D., et al. Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective casecohort study. Lancet Neurol 2006; 5: 655-660.
    • (2006) Lancet Neurol , vol.5 , pp. 655-660
    • Van Oijen, M.1    Hofman, A.2    Soares, H.D.3
  • 27
    • 29744469446 scopus 로고    scopus 로고
    • Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: A prospective study
    • Ravaglia G., Paola F., Maioli F., et al. Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study. Exp Gerontol 2006; 41: 85-92.
    • (2006) Exp Gerontol , vol.41 , pp. 85-92
    • Ravaglia, G.1    Paola, F.2    Maioli, F.3
  • 28
    • 73649085771 scopus 로고    scopus 로고
    • Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease
    • Capurso C., Solfrizzi V., Colacicco A.M., et al. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2010; 1: 177-182.
    • (2010) Prog Neuropsychopharmacol Biol Psychiatry , vol.1 , pp. 177-182
    • Capurso, C.1    Solfrizzi, V.2    Colacicco, A.M.3
  • 29
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force of Alzheimer's disease
    • McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force of Alzheimer's disease. Neurology 1984; 34: 939-944.
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3
  • 30
    • 78651254457 scopus 로고    scopus 로고
    • Severity of explicit memory impairment due to Alzheimer's disease improves effectiveness of implicit learning
    • Klimkowicz-Mrowiec A., Slowik A., Krzywoszañski L., et al. Severity of explicit memory impairment due to Alzheimer's disease improves effectiveness of implicit learning. J Neurol 2008; 20: 234-240.
    • (2008) J Neurol , vol.20 , pp. 234-240
    • Klimkowicz-Mrowiec, A.1    Slowik, A.2    Krzywoszañski, L.3
  • 31
    • 0016823810 scopus 로고
    • 'Mini Mental State': A practical method for grading the cognitive state of patients for the clinician
    • Folstein M.F., Folstein S.E., McHugh P.R. 'Mini Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
    • (1975) J Psychiatr Res , vol.12 , pp. 189-198
    • Folstein, M.F.1    Folstein, S.E.2    McHugh, P.R.3
  • 32
    • 0027282035 scopus 로고
    • Apolipoprotein E polymorphism and Alzheimer's disease
    • Poirier J., Davignon J., Bouthillier D., et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 18: 697-699.
    • (1993) Lancet , vol.18 , pp. 697-699
    • Poirier, J.1    Davignon, J.2    Bouthillier, D.3
  • 33
    • 0028167193 scopus 로고
    • Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease
    • Brousseau T., Legrain S., Berr C., et al. Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 1994; 44: 342-344.
    • (1994) Neurology , vol.44 , pp. 342-344
    • Brousseau, T.1    Legrain, S.2    Berr, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.